Stock Events

Stock Events

Search...

Fate Therapeutics (FATE) Q3 2024 Earnings

13AugConfirmed

Q3 2023

Q4 2023

Q2 2024

Q3 2024

-0.57

-0.49

-0.41

-0.33

Details

Expected EPS

-0.46354

Actual EPS

-0.33

Surprise EPS

0.13

Surprise Percent

+28.81%

Description

Fate Therapeutics (FATE) has reported earnings of -0.33 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.